| 2001 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Germany |
68 |
| 2002 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Germany |
62 |
| 2003 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Germany |
48 |
| 2004 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
USA |
63 |
| 2005 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2024 |
Standard Therapy |
Spain |
58 |
| 2006 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
41 |
| 2007 |
Apheresis |
Allogeneic |
Myelofibrosis Myeloid Metaplasia |
Hematology |
2024 |
Standard Therapy |
USA |
73 |
| 2008 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
15 |
| 2009 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Germany |
65 |
| 2010 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
38 |
| 2011 |
Apheresis |
Allogeneic |
Plasmacytoma |
Hematology |
2024 |
Standard Therapy |
Poland |
46 |
| 2012 |
Apheresis |
Autologous |
Multiple myeloma |
Hematology |
2024 |
Standard Therapy |
Portugal |
60 |
| 2013 |
Apheresis |
Autologous |
Multiple myeloma |
Hematology |
2024 |
Standard Therapy |
Portugal |
60 |
| 2014 |
Skeletal Muscle |
Allogeneic – Related |
Duchenne Muscular Dystrophy (DMD) |
Genetic disorder |
2023 |
Experimental Therapy |
Poland |
8 |
| 2015 |
Skeletal Muscle |
Allogeneic – Related |
Duchenne Muscular Dystrophy (DMD) |
Genetic disorder |
2023 |
Experimental Therapy |
Poland |
16 |
| 2016 |
Cord Tissue |
Allogeneic – Related |
Ags (Autism + Epilepsy) |
Neurology |
2023 |
Experimental Therapy |
Poland/Romania |
15 |
| 2017 |
Cord Tissue |
Allogeneic – Related |
Autism |
Neurology |
2023 |
Experimental Therapy |
Romania |
8,5 |
| 2018 |
Cord Tissue |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Hungary |
10 |
| 2019 |
Cord Tissue |
Allogeneic – Related |
Autism |
Neurology |
2023 |
Experimental Therapy |
Romania |
4 |
| 2020 |
Cord Tissue |
Allogeneic – Related |
Autism |
Neurology |
2023 |
Experimental Therapy |
Romania |
10 |
| 2021 |
Cord Tissue |
Allogeneic – Related |
Autism |
Neurology |
2023 |
Experimental Therapy |
Romania |
3,2 |
| 2022 |
Cord Tissue |
Autologous |
Cerebral Palsy |
Neurology |
2023 |
Experimental Therapy |
Romania |
2 |
| 2023 |
Cord Tissue |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2023 |
Experimental Therapy |
Romania |
3 |
| 2024 |
Cord Tissue |
Allogeneic – Unrelated |
Disorders Of Optic Nerve |
Ophthalmology |
2023 |
Experimental Therapy |
Poland |
39,1 |
| 2025 |
Cord Tissue |
Allogeneic – Unrelated |
Gonarthrosis |
Orthopedy |
2023 |
Experimental Therapy |
Poland |
65,1 |
| 2026 |
Cord Tissue |
Allogeneic – Unrelated |
Gonarthrosis |
Orthopedy |
2023 |
Experimental Therapy |
Poland |
50,8 |
| 2027 |
Cord Tissue |
Allogeneic – Unrelated |
Graft Versus Host Disease |
Hematology |
2023 |
Experimental Therapy |
Poland |
8 months |
| 2028 |
Cord Tissue |
Allogeneic – Unrelated |
Graft Versus Host Disease |
Hematology |
2023 |
Experimental Therapy |
Poland |
16,2 |
| 2029 |
Cord Tissue |
Allogeneic – Unrelated |
Internal Damage To The Knee Joint |
Orthopedy |
2023 |
Experimental Therapy |
Poland |
20,8 |
| 2030 |
Cord Tissue |
Allogeneic – Unrelated |
Internal Damage To The Knee Joint |
Orthopedy |
2023 |
Experimental Therapy |
Poland |
49,8 |
| 2031 |
Cord Tissue |
Allogeneic – Unrelated |
Internal Damage To The Knee Joint |
Orthopedy |
2023 |
Experimental Therapy |
Poland |
62,7 |
| 2032 |
Cord Tissue |
Allogeneic – Unrelated |
Internal Damage To The Knee Joint |
Orthopedy |
2023 |
Experimental Therapy |
Poland |
24,1 |
| 2033 |
Cord Tissue |
Allogeneic – Unrelated |
Mucopolysaccharidosis Type Ii |
Hematology |
2023 |
Experimental Therapy |
Poland |
4,7 |
| 2034 |
Cord Tissue |
Allogeneic – Unrelated |
Non-Inflammatory Diseases Of The Ovary, Fallopian Tube, And Broad Ligament Of The Uterus |
Gynecology |
2023 |
Experimental Therapy |
Poland |
47 |
| 2035 |
Cord Tissue |
Autologous |
Optic Nerve Atrophy, Tetraparesis, Hydrocephalus |
Neurology |
2023 |
Experimental Therapy |
Romania |
5,5 |
| 2036 |
Cord Tissue |
Allogeneic – Unrelated |
Ovarian Dysfunction |
Gynecology |
2023 |
Experimental Therapy |
Poland |
44,8 |
| 2037 |
Cord Tissue |
Allogeneic – Unrelated |
Ovarian Dysfunction |
Gynecology |
2023 |
Experimental Therapy |
Poland |
32,11 |
| 2038 |
Cord Tissue |
Allogeneic – Unrelated |
Polycystic Ovary Syndrome |
Gynecology |
2023 |
Experimental Therapy |
Poland |
39,4 |
| 2039 |
Cord Tissue |
Allogeneic – Related |
Right Parietal Closed Schizencephaly |
Neurology |
2023 |
Experimental Therapy |
Romania |
38 |
| 2040 |
Cord Tissue |
Allogeneic – Related |
Rp+ Usher Syndrome |
Neurology |
2023 |
Experimental Therapy |
Romania |
10 |
| 2041 |
Cord Tissue |
Allogeneic – Related |
Sudden Sensorineural Hearing Loss (Ssnhl) |
Neurology |
2023 |
Experimental Therapy |
Romania |
1 |
| 2042 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Hungary |
10 |
| 2043 |
Cord Blood |
Allogeneic |
Autism |
Neurology |
2023 |
Experimental Therapy |
Poland |
3,3 |
| 2044 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Romania |
3 |
| 2045 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Romania |
3 |
| 2046 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Romania |
10 |
| 2047 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Portugal |
7 |
| 2048 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Portugal |
5 |
| 2049 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Hungary |
14 |
| 2050 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Romania |
10 |
| 2051 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Hungary |
3 |
| 2052 |
Cord Blood |
Allogeneic – Related |
Autism |
Neurology |
2023 |
Experimental Therapy |
Romania |
3,2 |
| 2053 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Hungary |
5 |
| 2054 |
Cord Blood |
Allogeneic – Related |
Beta Thalassemia |
Hematology |
2023 |
Standard Therapy |
UK |
8 |
| 2055 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2023 |
Experimental Therapy |
Hungary |
5 |
| 2056 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2023 |
Standard Therapy |
UK |
2,5 |
| 2057 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2023 |
Standard Therapy |
UK |
2,5 |
| 2058 |
Cord Blood |
Autologous |
Cerebral Palsy |
Neurology |
2023 |
Experimental Therapy |
Poland |
2,1 |
| 2059 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2023 |
Experimental Therapy |
Romania |
10 |
| 2060 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy, Psychomotor Retard, Tetraparesis, Microcephaly |
Neurology |
2023 |
Experimental Therapy |
Romania |
9 |
| 2061 |
Cord Blood |
Autologous |
Global Developmental Delay Si Truncal Ataxia |
Neurology |
2023 |
Experimental Therapy |
Romania |
5 |
| 2062 |
Cord Blood |
Allogeneic |
Neuroblastoma |
Hematology |
2023 |
Standard Therapy |
Turkey |
2,1 |
| 2063 |
Cord Blood |
Allogeneic – Related |
Neuroblastoma |
Hematology |
2023 |
Standard Therapy |
Turkey |
2,1 |
| 2064 |
Cord Blood |
Autologous |
Optic Nerve Atrophy, Tetraparesis, Hydrocephalus |
Neurology |
2023 |
Experimental Therapy |
Romania |
5,5 |
| 2065 |
Cord Blood |
Autologous |
Pervasive Developmental Disorder |
Neurology |
2023 |
Experimental Therapy |
Poland |
3,11 |
| 2066 |
Cord Blood |
Autologous |
Pervasive Developmental Disorder |
Neurology |
2023 |
Experimental Therapy |
Poland |
8,1 |
| 2067 |
Cord Blood |
Allogeneic – Related |
Spasmodic Torticollis |
Neurology |
2023 |
Experimental Therapy |
Romania |
41 |
| 2068 |
Cord Blood |
Allogeneic |
Thalassemia Major |
Hematology |
2023 |
Standard Therapy |
Turkey |
17,4 |
| 2069 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2023 |
Standard Therapy |
Turkey |
17,4 |
| 2070 |
Cord Blood |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
5 months |
| 2071 |
Cord Blood |
Autologous |
Autism |
Neurology |
2023 |
Experimental Therapy |
Slovakia |
2 |
| 2072 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
42 |
| 2073 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
41 |
| 2074 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
35 |
| 2075 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
59 |
| 2076 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
50 |
| 2077 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
51 |
| 2078 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
59 |
| 2079 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
42 |
| 2080 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
21 |
| 2081 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
67 |
| 2082 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2083 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
39 |
| 2084 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
53 |
| 2085 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
42 |
| 2086 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2087 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
49 |
| 2088 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
61 |
| 2089 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
43 |
| 2090 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2091 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
56 |
| 2092 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2093 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2094 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2095 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
61 |
| 2096 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
47 |
| 2097 |
Bone Marrow Family |
Allogeneic |
B-Cell Precursor Acute Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
30 |
| 2098 |
Bone Marrow Family |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
69 |
| 2099 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
60 |
| 2100 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
70 |